• Hill-Rom
  • Welch Allyn
  • Bariatric Care
  • LikoGuard


  • Hill-Rom Introduces The VisiVest™ System, the World's First Connected Airway Clearance System

    CHICAGO, June 16, 2016 - Hill-Rom Holdings, Inc. (NYSE: HRC), a leading global medical technology company, today announced the introduction of the VisiVest System, a connected therapeutic solution for patients in need of airway clearance therapy. The world's first solution combining industry-leading high-frequency chest-wall oscillation (HFCWO) technology with wireless connectivity powered by Qualcomm Life, Inc., a subsidiary of Qualcomm Incorporated, the VisiVest System provides therapy adherence data that may help inform decisions caregivers make for their patients, resulting in reduced risk of respiratory infections, hospitalizations, and medical costs. 

    Hill-Rom to Participate in the Goldman Sachs 37th Annual Global Healthcare Conference

    CHICAGO, May 24, 2016 - Hill-Rom Holdings, Inc., (NYSE: HRC) invites you to listen to a management presentation at the Goldman Sachs 37th Annual Global Healthcare Conference on Tuesday, June 7, 2016, at 11:00 a.m. EDT.

    Haldor Advanced Technologies Ltd. and Hill-Rom Enter into Exclusive Global Distribution Partnership to Distribute Haldor's ORLocate® Suite of Products

    Cherry Hill, New Jersey, Chicago, Illinois, May 11, 2016 - Haldor Advanced Technologies Ltd. ("Haldor"), a developer of medical technology products, announced today that it has entered into an exclusive global distribution agreement with Hill-Rom (NYSE: HRC), a leading global medical technology company. The agreement covers the exclusive distribution of Haldor's market leading ORLocate® suite of products and technology.

    Hill-Rom Reports Higher Year-Over-Year Revenue And Adjusted Earnings And Updates Full Year Outlook

    CHICAGO, April 29, 2016 - Hill-Rom Holdings, Inc. (NYSE: HRC) announced financial results for its second quarter ended March 31, 2016, and updated its fiscal year 2016 financial outlook. Adjusted earnings per diluted share of $0.71 represent an increase of 11 percent from $0.64 in the prior year, while reported earnings per diluted share decreased 27 percent from $0.45 to $0.33. Adjustments to reported earnings are detailed in the reconciliation schedules provided.